An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors (Q38000038)

26 August 2017

An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors (English)

1 reference

26 August 2017

1 reference

Yin Ting Cheung

1

0 references

Alexandre Chan

object named as

Alexandre Chan

series ordinal

3

0 references

author name string

Earl Hsien-Jie Tan

series ordinal

2

1 reference

26 August 2017

5 April 2012

1 reference

Supportive Care in Cancer

26 August 2017

1 reference

26 August 2017

20

1 reference

26 August 2017

7

1 reference

26 August 2017

1361-1375

1 reference

https://scigraph.springernature.com/pub.10.1007/s00520-012-1445-4

26 August 2017

0 references

cites work

International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Cognitive function after chemotherapy in adults with solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Subjective cognitive dysfunction in breast cancer patients: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Cognitive impairment associated with adjuvant therapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Assessment practices of clinical neuropsychologists in the United States and Canada: a survey of INS, NAN, and APA Division 40 members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Psychological test usage: Implications in professional psychology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Validity of the construct of nonverbal memory: a factor-analytic study in a normal elderly sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Methodological problems in the neuropsychological assessment of effects of exposure to welding fumes and manganese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Assessing cognitive function in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Cognitive function in breast cancer patients receiving adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Prospective assessment of emotional distress, cognitive function, and quality of life in patients with cancer treated with chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

CANTAB battery: proposed utility in neurotoxicology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Development and validation of a web-based screening tool for monitoring cognitive status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Computerized and conventional neuropsychological assessment of HIV-1-infected homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

The Cognitive Failures Questionnaire (CFQ) and its correlates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Development and validation of a Multiple Ability Self-Report Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Cognitive impairments associated with breast cancer treatments: results from a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Cognitive functioning in breast cancer survivors: a controlled comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

A prospective study of cognitive complaints in patients with testicular cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Chemobrain: is systemic chemotherapy neurotoxic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Applications of computer-based neuropsychological assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Mild cognitive impairment: conceptual issues and structural and functional brain correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Predictors of cognitive decline after chemotherapy in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

'Chemobrain' in breast carcinoma?: a prologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma: daily self-report and objective behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

The reaction of psychiatric patients to computerized assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Psychometric issues associated with computerised neuropsychological assessment of concussed athletes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Computerised neuropsychological testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

CogSport: reliability and correlation with conventional cognitive tests used in postconcussion medical evaluations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

The Attentional Function Index--a self-report cognitive measure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Test-retest stability and practice effects of the RBANS in a community dwelling elderly sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Effect of repeated administration of a neuropsychological battery in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Construct and concurrent validity of the Hopkins Verbal Learning Test-revised.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Test-retest reliability of three aphasia tests: performance of non-brain-damaged older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

The reliability and validity of qualitative scores for the Controlled Oral Word Association Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

The (mis)classification of chemo-fog – methodological inconsistencies in the investigation of cognitive impairment after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00520-012-1445-4

21 January 2018

12 December 2020

Comparison of seven-subtest and Satz-Mogel short forms of the WAIS-III

1 reference

12 December 2020

The effects of anticancer chemotherapeutic drugs on cognitive function and other neuropsychiatric dimensions in breast cancer patients

1 reference

12 December 2020

The development and initial validation of a sensitive bedside cognitive screening test.

1 reference

12 December 2020

Cognitive changes in multiethnic Asian breast cancer patients: a focus group study.

1 reference

12 December 2020

Development and preliminary validation of a Satz-Mogel short form of the WAIS-III in a sample of persons with substance abuse disorders

1 reference

12 December 2020

Conners' Continuous Performance Test (2nd ed.; CCPT-II)

1 reference

12 December 2020

Repeated testing of normal elderly with the Boston Naming Test.

1 reference

12 December 2020

Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy

1 reference

12 December 2020

Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects

1 reference

12 December 2020

Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives

1 reference

12 December 2020

A comparison of computerized and standard versions of the Wisconsin Card Sorting Test

1 reference

12 December 2020

Neuro-cognitive impairment in breast cancer patients: pharmacological considerations

1 reference

12 December 2020

The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy

1 reference

12 December 2020

Cognitive functions and elderly cancer patients receiving anticancer treatment: A prospective study

1 reference

12 December 2020

10.1007/S00520-012-1445-4

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22476439